Literature DB >> 6198427

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.

D R Milich, G G Leroux-Roels, R E Louie, F V Chisari.   

Abstract

We have previously demonstrated that the murine humoral immune responses to the group-specific a and subtype-specific d/y determinants of hepatitis B surface antigen (HBsAg) are controlled by H-2-linked immune response (Ir) genes. High responder (H-2d,q), intermediate responder (H-2a greater than b greater than k) and nonresponder (H-2f,s) haplotypes have been identified (8, 9). The kinetics and specificity of in vivo antibody production after HBsAg immunization in congeneic, H-2-recombinant strains was analyzed to further define relevant Ir genes and their influence on the immune response to distinct antigenic determinants. These studies indicate that the humoral anti-HBs response is regulated by at least two Ir genes, one in the I-A subregion (Ir-HBs-1) and one in the I-C subregion (Ir-HBs-2) of the murine H-2 complex. Ir-HBs-1 regulates the primary responses to all HBsAg determinants, whereas the influence of Ir-HBs-2 is determinant specific, affecting the responses to the d or y determinants. The anti-a response is regulated exclusively by Ir-HBs-1. Strains possessing only the Ir-HBs-2 gene [B10.S(9R) and B10.HTT] produce no anti-a response and a subtype-specific antibody response is detected only after secondary or tertiary immunization. In contrast, the influence of Ir-HBs-2 in the presence of Ir-HBs-1 is detected upon primary immunization and is additive rather than exclusive. There is also suggestive evidence that the presence of the Ek molecule, at least in the context of I-Ak, may have a suppressive influence on the anti-HBs response. Additionally, HBsAg-specific, T cell proliferative responses were H-2 restricted and the kinetics and specificity of T cell proliferative responses paralleled in vivo antibody production. These data indicate that, although the I-A subregion exerts a dominant influence, distinct Ir-HBs genes, mapping in separate I subregions, control immune responses to alternate HBsAg determinants on the same protein molecule.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198427      PMCID: PMC2187186          DOI: 10.1084/jem.159.1.41

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  T-cell dependence of immune response to hepatitis B antigen in mice.

Authors:  I M Roberts; C C Bernard; G N Vyas; I R Mackay
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

2.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

Review 3.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

4.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). III. Circumvention of nonresponsiveness in mice bearing HBsAg nonresponder haplotypes.

Authors:  D R Milich; H Alexander; F V Chisari
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

5.  Structure of hepatitis B surface antigen. Correlation of subtype with amino acid sequence and location of the carbohydrate moiety.

Authors:  D L Peterson; N Nath; F Gavilanes
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

6.  Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits.

Authors:  J L Gerin; R M Faust; P V Holland
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

7.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

8.  A possible immunodominant epitope recognized by murine T lymphocytes immune to different myoglobins.

Authors:  I Berkower; G K Buckenmeyer; F R Gurd; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). II. Qualitative characteristics of the humoral immune response to the a, d, and y determinants of HBsAg.

Authors:  D R Milich; G G Leroux-Roels; F V Chisari
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  The functional dissection of an antigen molecule: specificity of humoral and cellular immune responses to glucagon.

Authors:  G Senyk; E B Williams; D E Nitecki; J W Goodman
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  22 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Distinct regulation of humoral and cellular immunities to hepatitis B surface antigen.

Authors:  H Y Lei; S C Lee; C K Yu
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

Authors:  E Egea; A Iglesias; M Salazar; C Morimoto; M S Kruskall; Z Awdeh; S F Schlossman; C A Alper; E J Yunis
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

4.  Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.

Authors:  P Christadoss; C S David; M Shenoy; S Keve
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 5.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing.

Authors:  A Krämer; D Herth; H J von Keyserlingk; W D Ludwig; H Hampl; D Sommer; E G Hahn; E O Riecken
Journal:  Klin Wochenschr       Date:  1988-08-01

7.  Igh allotype-linked control of immune complex-type hypersensitivity induced by hepatitis B surface antigen.

Authors:  H Y Lei; S C Lee
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

8.  Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.

Authors:  S P Chang; G S Hui; A Kato; W A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.

Authors:  Isabelle Desombere; Annick Willems; Yvonne Gijbels; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 10.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.